Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSTN.L Regulatory News (HSTN)

  • There is currently no data for HSTN

Update on 2019 AGM voting outcome

3 Dec 2019 09:00

RNS Number : 4116V
Hansteen Holdings plc
03 December 2019
 

3 December 2019

HANSTEEN HOLDINGS PLC

("Hansteen", the "Company" or, the "Group")

 

 

Update on 2019 AGM voting outcome

 

 

In its 2019 AGM results announcement on 11 June 2019, the Company reported that all resolutions were passed, although there was a significant minority vote against the following resolutions:

 

·; Resolution 2 which related to the approval of the Annual Report on Remuneration. Total votes received in favour of this resolution were 73.13%; and

 

·; Resolution 7 which related to the re-election of Melvyn Egglenton, the Chairman of the Company, as a non-executive Director. Total votes received in favour of this resolution were 62.53%

 

In consultation with major shareholders, the Chairman and the Senior Independent Director identified that the reason behind the dissenting votes for Resolution 2 related to the final payment under the Founder Long Term Incentive Plan and Resolution 7 related to the absence of female representation on the Board:

 

Resolution 2

 

No further awards will be made under this Plan and therefore the reason for the votes against the Resolution no longer exists.

 

Resolution 7

 

When deciding whether to recruit a new non-executive Director to replace Margaret Young, who stepped down as a non-executive Director of the Company on 31 December 2018, the Board considered the significant reduction in the size of the Company from net assets of £924.2 million at 31 December 2016 to £470.1 million at 31 December 2018 and its expectations for the future. The reduction in net assets resulted from the disposal of property assets realising substantial profits followed by the return of capital to shareholders of £578.1 million in November 2017 and £144.5 million in May 2018.

 

Although there has been a significant reduction in the net assets, market capitalisation of the Company and complexity of the Group in the two years to 31 December 2018, the Company has maintained, and continues to maintain its strong control environment, high level of internal controls and robust processes. In light of the foregoing, the Board decided not to replace Margaret Young with another non-executive Director. This decision remains under review by the Board, and it will take into account any possible significant changes in the activities and/or size of the Company in the future and the Board would expect that any future additional appointments to the Board to reflect the desired expertise and background of potential candidates to complement the skills already on the Board while ensuring consideration of ethnicity and gender diversity, as part of the Company's recruitment process.

 

The Board will continue to engage with shareholders on the size, composition and diversity of the Board and will set out further details of any such consultation in the 2019 Annual Report and Accounts and associated documentation.

 

Enquiries:

Hansteen Holdings PLCMel Egglenton, Chairman

Morgan Jones, joint Chief ExecutiveIan Watson, joint Chief Executive

Tel: +44 (0) 20 7408 7000

www.hansteen.co.uk

Tavistock Jeremy Carey 

Tel: +44 (0) 20 7920 3150

jeremy.carey@tavistock.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUUVWRKBAURAA
Date   Source Headline
18th Dec 20147:00 amRNSDisposals
8th Dec 20147:00 amRNSAcquisitions
12th Nov 20147:00 amRNSDisposal
6th Nov 20147:00 amRNSAcquisition
3rd Nov 20147:00 amRNSDisposal
6th Oct 20143:39 pmRNSDividend Declaration
9th Sep 20144:37 pmRNSHolding(s) in Company
27th Aug 20147:00 amRNSHalf Yearly Report
18th Aug 20145:38 pmRNSHolding(s) in Company
25th Jul 20148:30 amRNSNotice of Results
30th Jun 20144:23 pmRNSTotal Voting Rights
30th Jun 20147:00 amRNSAcquisition
19th Jun 201410:45 amRNSTransaction in Own Shares
10th Jun 201410:38 amRNSHolding(s) in Company
10th Jun 20147:00 amRNSDirectorate Changes
9th Jun 20144:38 pmRNSTransaction in Own Shares
9th Jun 20144:27 pmRNSResult of AGM
6th Jun 20147:00 amRNSDisposal
29th May 20141:22 pmRNSHolding(s) in Company
16th May 20147:00 amRNSInterim Management Statement
14th May 20149:57 amRNSHolding(s) in Company
9th May 20143:32 pmRNSNotice of Adjustment to Bond Conversion Price
2nd May 201410:51 amRNSNotice of AGM
30th Apr 201410:04 amRNSTotal Voting Rights
17th Apr 20144:10 pmRNSAnnual Financial Report
14th Apr 20143:18 pmRNSDirector/PDMR Shareholding
3rd Apr 20143:25 pmRNSTransactions by Directors
3rd Apr 20143:20 pmRNSHolding(s) in Company
2nd Apr 20144:00 pmRNSHolding(s) in Company
28th Mar 20147:01 amRNSAcquisition and Placing
21st Mar 201411:55 amRNSDividend Declaration
11th Mar 20147:00 amRNSFinal Results
5th Mar 20148:00 amRNSTotal Voting Rights
4th Mar 20147:00 amRNSHansteen refinances German portfolio
3rd Mar 20144:28 pmRNSHolding(s) in Company
11th Feb 20147:00 amRNSAcquisition
4th Feb 20142:30 pmRNSChange of Announcement Date
31st Jan 20141:00 pmRNSHolding(s) in Company
31st Jan 201411:49 amRNSHolding(s) in Company
24th Jan 20148:52 amRNSNotice to Bondholders
7th Jan 201411:29 amRNSNotice of Results
7th Jan 20147:00 amRNSDisposals
23rd Dec 20137:00 amRNSLoan Acquisition
28th Nov 201310:51 amRNSDirector Shareholding
26th Nov 201310:05 amRNSAcquisition Minority Interest in Hansteen Ormix BV
22nd Nov 201310:01 amRNSBlocklisting Application
14th Nov 20137:00 amRNSInterim Management Statement
11th Nov 201310:32 amRNSDirectorate Change
23rd Sep 201310:45 amRNSHolding(s) in Company
13th Sep 201310:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.